These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6106513)

  • 1. Neurotensin: perchance an endogenous neuroleptic?
    Nemeroff CB
    Biol Psychiatry; 1980 Apr; 15(2):283-302. PubMed ID: 6106513
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neuroleptic-like activity of the tripeptide neurotensin analog GZR-123].
    Guzevatykh LS; Ostrovskaia RU; Gudasheva TA; Zaĭtseva NI; Voronina TA
    Eksp Klin Farmakol; 2002; 65(1):3-6. PubMed ID: 12025780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticholinergics promote neuroleptic-induced tardive dyskinesia.
    Borison RL; Diamond BI
    Adv Biochem Psychopharmacol; 1980; 24():359-61. PubMed ID: 6105786
    [No Abstract]   [Full Text] [Related]  

  • 4. Interactions of neurotensin with brain dopamine systems.
    Nemeroff CB; Hernandez DE; Luttinger D; Kalivas PW; Prange AJ
    Ann N Y Acad Sci; 1982; 400():330-44. PubMed ID: 6132577
    [No Abstract]   [Full Text] [Related]  

  • 5. Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues.
    Hadden MK; Orwig KS; Kokko KP; Mazella J; Dix TA
    Neuropharmacology; 2005 Dec; 49(8):1149-59. PubMed ID: 16095636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
    Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
    Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological studies on timiperone, a new neuroleptic drug. Part I: Behavior effects.
    Yamasaki T; Kojima H; Sakurai T; Kasahara A; Watanabe S; Fujiwara M; Ueki S
    Arzneimittelforschung; 1981; 31(4):701-7. PubMed ID: 6113833
    [No Abstract]   [Full Text] [Related]  

  • 8. Electrophysiological and behavioral effects of neurotensin in rat globus pallidus: an in vivo study.
    Xue Y; Chen L; Cui QL; Xie JX; Yung WH
    Exp Neurol; 2007 May; 205(1):108-15. PubMed ID: 17362935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.
    Haleem DJ; Samad N; Haleem MA
    Pharmacol Biochem Behav; 2007 May; 87(1):115-21. PubMed ID: 17498786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of typical and atypical antipsychotic drugs on neurotensin-containing neurons in the central nervous system.
    Kinkead B; Nemeroff CB
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():30-2. PubMed ID: 7961568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injection of apomorphine--a test to predict individual different dopaminergic sensitivity?
    Surmann A; Havemann-Reinecke U
    J Neural Transm Suppl; 1995; 45():143-55. PubMed ID: 8748620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
    Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
    J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of neurotensin injections into caudate nuclei on realization and extinction of conditioned motor reflex in rats].
    Shugalev NP; Ol'shanskiĭ AS; Hartmann G
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2001; 51(4):473-6. PubMed ID: 11605426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly potent neurotensin analog that causes hypothermia and antinociception.
    Tyler-McMahon BM; Stewart JA; Farinas F; McCormick DJ; Richelson E
    Eur J Pharmacol; 2000 Feb; 390(1-2):107-11. PubMed ID: 10708713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antagonism of straightening and stereotyped behavior and of hypothermia induced by 1 or 16 mg/kg-1 of apomorphine].
    J Pharmacol; 1983; 14(1):93-7. PubMed ID: 6682162
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuropharmacological studies on the neuroleptic potential of domperidone (R33812).
    Costall B; Fortune DH; Naylor RJ
    J Pharm Pharmacol; 1979 May; 31(5):344-7. PubMed ID: 37312
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioral supersensitivity to beta-phenylethylamine after chronic administration of haloperidol.
    Stoff DM; Jeste DV; Gillin JC; Moja EA; Cohen L; Stauderman KA; Wyatt RJ
    Biol Psychiatry; 1984 Jan; 19(1):101-6. PubMed ID: 6538440
    [No Abstract]   [Full Text] [Related]  

  • 19. Increase of neurotensin content elicited by neuroleptics in nucleus accumbens.
    Govoni S; Hong JS; Yang HY; Costa E
    J Pharmacol Exp Ther; 1980 Nov; 215(2):413-7. PubMed ID: 6108359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis and the effect of new derivatives of perhydro-1,4,6-oxadiazocine on the central nervous system].
    Brzezińska E; Glinka R; Szadowska A; Kiełek MB
    Acta Pol Pharm; 1988; 45(5):400-5. PubMed ID: 2907843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.